نتایج جستجو برای: chronic gvhd

تعداد نتایج: 500551  

Journal: :Clinical molecular pathology 1996
S Aractingi E Gluckman C Le Goué L Dubertret E D Carosella

Aims-To determine which inflammatory and immune pathways are implicated in the development of chronic graft versus host disease (GvHD) and whether differences between these pathways are responsible for the different presentations of chronic GvHD.Methods-Biopsy specimens of diseased and normal skin were obtained from patients presenting with lichen planus-like and sclerodermatous type chronic Gv...

2006
Kirk R. Schultz David B. Miklos Daniel Fowler Ken Cooke Judith Shizuru Emmanuel Zorn Ernst Holler James Ferrara Howard Shulman Stephanie J. Lee Paul Martin Alexandra H. Filipovich Mary E. D. Flowers Daniel Weisdorf Daniel Couriel Peter A. Lachenbruch Barbara Mittleman Georgia B. Vogelsang Steven Z. Pavletic

Biology-based markers that can be used to confirm the diagnosis of chronic graft-versus-host disease (GVHD) or monitor progression of the disease could help in the evaluation of new therapies. Biomarkers have been defined as any characteristic that is objectively measured and evaluated as an indicator of a normal biologic or pathogenic process, a pharmacologic response to a therapeutic interven...

2012
Ju Young Yoon Hyery Kim Hyoung Jin Kang Kyung Duk Park Hee Young Shin Hyo Seop Ahn

Chronic graft versus host disease (GVHD) is a frequent complication after allogeneic hematopoietic stem cell transplantation (HSCT), but simultaneous small bowel obstruction is rare. Here, we report a child with acute myeloid leukemia who received an allogeneic HSCT from an unrelated matched donor. After HSCT, the patient developed severe chronic GVHD involving the small intestine, leading to o...

2013
Natasha Ali Salman Naseem Adil Mohammad Usman Shaikh Nehal Masood

Objective. The objective of this study was to evaluate the frequency and outcome of graft versus host disease after stem cell transplantation for various haematological disorders in Pakistan. Materials and Methods. Pretransplant workup of the patient and donor was performed. Mobilization was done with G-CSF 300  μ g twice daily for five day. Standard GvHD prophylaxis was done with methotrexate ...

Journal: :Blood 2014
Gérard Socié Jerome Ritz

Chronic graft-versus-host disease (GVHD) is a frequent and potentially life-threatening complication of allogeneic hematopoietic stem cell transplantation. Increased transplantation of older patients and the more frequent use of unrelated donors has led to increased numbers of patients with this painful complication. Recent advances have been made in understanding the pathophysiology of chronic...

Journal: :Haematologica 2006
Cristina Skert Francesca Patriarca Alessandra Sperotto Michela Cerno Carla Filì Francesco Zaja Raffaella Stocchi Antonella Geromin Daniela Damiani Renato Fanin

Scleroderma may be one of the most severe forms of chronic graft-versus-host disease (GVHD). We retrospectively evaluated its incidence, predictor variables and outcome in 133 patients who survived at least 4 months after allogeneic hematopoietic stem cell transplantation. The 5-year cumulative incidence was 15.5% in patients with chronic GVHD. The generalized form had a progressive course desp...

Journal: :Transplantation 2000
N Murase Q Ye M A Nalesnik A J Demetris K Abu-Elmagd J Reyes N Ichikawa T Okuda J J Fung T E Starzl

BACKGROUND The passenger leukocytes in the intestine have a lineage profile that predisposes to graft-versus-host disease (GVHD) in some animal models and have inferior tolerogenic qualities compared with the leukocytes in the liver, other solid organs, and bone marrow. Elimination by ex vivo irradiation of mature lymphoid elements from the bowel allografts is known to eliminate the GVHD risk. ...

Journal: :Journal of immunology 2003
Miho Sasaki Hitoshi Hasegawa Masashi Kohno Atsushi Inoue Mitsuko R Ito Shigeru Fujita

The use of receptor antagonists for chemokines is an alternative approach to blocking chemokine actions and has the potential to provide novel therapeutics. We determined the receptor antagonist properties of murine N-terminally truncated secondary lymphoid tissue chemokine (SLC)/6Ckine/CCR ligand 21 analogs and evaluated the preventive effects of SLC antagonists on chronic graft-vs-host diseas...

Journal: :Blood 2014
Javier Bolaños-Meade Brent R Logan Amin M Alousi Joseph H Antin Kate Barowski Shelly L Carter Steven C Goldstein Elizabeth O Hexner Mary M Horowitz Stephanie J Lee John E Levine Margaret L MacMillan Paul J Martin Adam M Mendizabal Ryotaro Nakamura Marcelo C Pasquini Daniel J Weisdorf Peter Westervelt Vincent T Ho

Corticosteroids are the accepted primary therapy for acute graft-versus-host disease (GVHD), but durable responses are seen in only about half of the patients. Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0802, a phase 3 multicenter randomized double-blinded trial, was designed to test whether mycophenolate mofetil (MMF) plus corticosteroids was superior to corticosteroids alon...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2006
L Barkholt M Bregni M Remberger D Blaise J Peccatori G Massenkeil P Pedrazzoli A Zambelli J-O Bay S Francois R Martino C Bengala M Brune S Lenhoff A Porcellini M Falda S Siena T Demirer D Niederwieser O Ringdén

BACKGROUND An allogeneic antitumour effect has been reported for various cancers. We evaluated the experience of allogeneic haematopoietic stem cell transplantation (HSCT) for renal cell carcinoma (RCC) in 124 patients from 21 European centres. PATIENTS AND METHODS Reduced intensity conditioning and peripheral blood stem cells from an HLA-identical sibling (n = 106), a mismatched related (n =...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید